IE
PMVP icon

Israel Englander’s PMV Pharmaceuticals PMVP Stock Holding History

Israel Englander’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,995
Closed -$25.4K – 6370
2025
Q2 		$25.4K Sell
23,995
-131,394
-85% -$129K ﹤0.01% 5665
2025
Q1 		$169K Sell
155,389
-162,631
-51% -$221K ﹤0.01% 5343
2024
Q4 		$480K Sell
318,020
-45,949
-13% -$72.8K ﹤0.01% 4783
2024
Q3 		$542K Sell
363,969
-394,771
-52% -$610K ﹤0.01% 4763
2024
Q2 		$1.23M Buy
758,740
+103,279
+16% +$186K ﹤0.01% 3957
2024
Q1 		$1.11M Buy
+655,461
New +$1.22M ﹤0.01% 4204
2023
Q4 		– Sell
-28,549
Closed -$175K – 6436
2023
Q3 		$175K Sell
28,549
-101,990
-78% -$701K ﹤0.01% 5171
2023
Q2 		$817K Sell
130,539
-211,613
-62% -$1.11M ﹤0.01% 4189
2023
Q1 		$1.63M Buy
342,152
+268,615
+365% +$1.89M ﹤0.01% 3631
2022
Q4 		$640K Sell
73,537
-86,959
-54% -$927K ﹤0.01% 4549
2022
Q3 		$1.91M Buy
+160,496
New +$2.32M ﹤0.01% 3781
2022
Q1 		– Sell
-68,845
Closed -$1.59M – 7355
2021
Q4 		$1.59M Buy
+68,845
New +$1.66M ﹤0.01% 3974
2021
Q2 		– Sell
-7,560
Closed -$249K – 6980
2021
Q1 		$249K Buy
+7,560
New +$298K ﹤0.01% 5345
2020
Q4 		– Sell
-280,425
Closed -$9.96K – 5503
2020
Q3 		$9.96K Buy
+280,425
New +$10.3M 0.01% 1252

Other funds holding PMVP

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Israel Englander's PMVP Position: Q3 2025 in Review

Israel Englander sold out of PMV Pharmaceuticals (PMVP) in Q3 2025, closing a stake of 23,995 shares — an estimated $25.4K sold.

Israel Englander first reported a position in PMVP in Q3 2020 and held it in 14 quarters. The position peaked at $1.91M in Q3 2022. 64 funds tracked by Wall St. Rank hold PMVP as of Q3 2025.

  • Israel Englander reported no remaining PMV Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Israel Englander sold 23,995 PMV Pharmaceuticals shares in Q3 2025, an estimated $25.4K.
  • Israel Englander first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 14 quarters.
  • Israel Englander's PMV Pharmaceuticals position peaked at $1.91M in Q3 2022.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.